Zobrazeno 1 - 10
of 266
pro vyhledávání: '"Nicolas, Mounier"'
Autor:
Marc P. E. André, Patrice Carde, Simonetta Viviani, Monica Bellei, Catherine Fortpied, Martin Hutchings, Alessandro M. Gianni, Pauline Brice, Olivier Casasnovas, Paolo G. Gobbi, Pier Luigi Zinzani, Jehan Dupuis, Emilio Iannitto, Alessandro Rambaldi, Josette Brière, Laurianne Clément‐Filliatre, Marian Heczko, Pinuccia Valagussa, Jonathan Douxfils, Julien Depaus, Massimo Federico, Nicolas Mounier
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6565-6575 (2020)
Abstract Purpose We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine, and prednisone (BEACOPP) over doxorubicin (Adriamycin), bleomycin, vinb
Externí odkaz:
https://doaj.org/article/937d510df6514257a183dcff6818f98b
Autor:
Raphaël Busson, Marleen van der Kaaij, Nicolas Mounier, Berthe M. P. Aleman, Catherine Thiéblemont, Aspasia Stamatoullas, Vincent Ribrag, Hervé Tilly, Corinne Haioun, René-Olivier Casasnovas, Hanneke C. Kluin-Nelemans, Michel Henry-Amar
Publikováno v:
Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-13 (2019)
Abstract Background Long-term lymphoma survivors often complain of persistent fatigue that remains unexplained. While largely reported in Hodgkin lymphoma (HL), long-term fatigue is poorly documented in non-Hodgkin lymphomas (NHL). Data collected in
Externí odkaz:
https://doaj.org/article/ae5f7853b2e3475eb0340f83e61a3688
Autor:
Aurélie Cabannes‐Hamy, Frederic Peyrade, Fabrice Jardin, Jean‐François Emile, Vincent Delwail, Nicolas Mounier, Corinne Haioun, Aurore Perrot, Olivier Fitoussi, Diane Lara, Richard Delarue, Marc André, Fritz Offner, Hervé Ghesquières, Laurent Pascal, Carole Soussain, Julien Lazarovici, Jean‐Marc Schiano, Philippe Gaulard, Hervé Tilly, Catherine Thieblemont, the LYSA, the lymphoma study association
Publikováno v:
Cancer Medicine, Vol 7, Iss 3, Pp 539-548 (2018)
Abstract CNS relapse is reported in 2–5% of diffuse large B‐cell lymphoma (DLBCL) patients, dramatically decreasing overall survival (OS). Very few studies address incidence and risk factors of CNS relapse in very elderly patients, a challenging
Externí odkaz:
https://doaj.org/article/2ef727845e234673965c422569014e42
Autor:
Nicolas Mounier, Christophe Guyeux, Macha Woronoff-Lemsi, David Sibon, Loic Ysebaert, Michel Henry-Amar, Virginie Nerich, Gandhi Damaj, Jean-Philippe Jais, Vincent Ribrag, Franck Morschhauser, Corinne Haioun, Pierre Feugier, Hervé Tilly, Florence Broussais-Guillaumot, Gilles Salles, Catherine Thieblemont, René-Olivier Casasnovas, Emmanuelle Nicolas-Virelizier, Raphaël Couturier
Publikováno v:
Cancer. 128:519-528
BACKGROUND No study has focused on the economic burden in non-Hodgkin lymphoma (NHL) survivors, even though this knowledge is essential. This study reports on health care resource use and associated health care costs as well as related factors in a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d2091701ec1bd063271e805e9ea35e2
https://doi.org/10.1002/cncr.33938
https://doi.org/10.1002/cncr.33938
Autor:
Catherine Thieblemont, Bettina Altmann, Fabian Frontzek, Loïc Renaud, Loic Chartier, Nicolas Ketterer, Christian Recher, Viola Poeschel, Olivier Fitoussi, Gerhard Held, René-Olivier Casasnovas, Corinne Haioun, Franck Morschhauser, Bertram Glass, Nicolas Mounier, Hervé Tilly, Andreas Rosenwald, German Ott, Georg Lenz, Thierry Molina, Marita Ziepert, Norbert Schmitz
The majority of patients with diffuse large B-cell lymphoma (DLBCL) can be cured with immunochemotherapy comprising rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). Patients suffering progression or relapse in the centr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54aabae0f1ecc16aebc9a013694cff9
https://doi.org/10.21203/rs.3.rs-1906423/v1
https://doi.org/10.21203/rs.3.rs-1906423/v1
Publikováno v:
European Journal of Cancer. 138:189-192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56afd10ee86dc03f10cbf81233fceb0a
https://doi.org/10.1016/j.ejca.2020.07.033
https://doi.org/10.1016/j.ejca.2020.07.033
Autor:
Pier Luigi Zinzani, Julien Depaus, P. Valagussa, Simonetta Viviani, Patrice Carde, Laurianne Clément-Filliatre, Jonathan Douxfils, Marc André, Olivier Casasnovas, Massimo Federico, Pauline Brice, Nicolas Mounier, Alessandro M. Gianni, Paolo G. Gobbi, Jehan Dupuis, Catherine Fortpied, Martin Hutchings, Emilio Iannitto, Monica Bellei, Marian Heczko, Alessandro Rambaldi, Josette Brière
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6565-6575 (2020)
Cancer Medicine
André, M P E, Carde, P, Viviani, S, Bellei, M, Fortpied, C, Hutchings, M, Gianni, A M, Brice, P, Casasnovas, O, Gobbi, P G, Zinzani, P L, Dupuis, J, Iannitto, E, Rambaldi, A, Brière, J, Clément-Filliatre, L, Heczko, M, Valagussa, P, Douxfils, J, Depaus, J, Federico, M & Mounier, N 2020, ' Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma : A pooled analysis of four randomized trials ', Cancer medicine, vol. 9, no. 18, pp. 6565-6575 . https://doi.org/10.1002/cam4.3298
Cancer medicine, Vol. 9, no. 18, p. 6565-6575 (2020)
Cancer Medicine
André, M P E, Carde, P, Viviani, S, Bellei, M, Fortpied, C, Hutchings, M, Gianni, A M, Brice, P, Casasnovas, O, Gobbi, P G, Zinzani, P L, Dupuis, J, Iannitto, E, Rambaldi, A, Brière, J, Clément-Filliatre, L, Heczko, M, Valagussa, P, Douxfils, J, Depaus, J, Federico, M & Mounier, N 2020, ' Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma : A pooled analysis of four randomized trials ', Cancer medicine, vol. 9, no. 18, pp. 6565-6575 . https://doi.org/10.1002/cam4.3298
Cancer medicine, Vol. 9, no. 18, p. 6565-6575 (2020)
Purpose We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine, and prednisone (BEACOPP) over doxorubicin (Adriamycin), bleomycin, vinblastine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99be92d20b893ec3b515374f66c11fc
https://researchportal.unamur.be/en/publications/2fc7e926-4cf9-4b61-870c-82a9e47fd29a
https://researchportal.unamur.be/en/publications/2fc7e926-4cf9-4b61-870c-82a9e47fd29a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Julien Lazarovici, Peggy Dartigues, Pauline Brice, Lucie Obéric, Isabelle Gaillard, Mathilde Hunault-Berger, Florence Broussais-Guillaumot, Emmanuel Gyan, Serge Bologna, Emmanuelle Nicolas-Virelizier, Mohamed Touati, Olivier Casasnovas, Richard Delarue, Frédérique Orsini-Piocelle, Aspasia Stamatoullas, Jean Gabarre, Luc-Matthieu Fornecker, Thomas Gastinne, Fréderic Peyrade, Virginie Roland, Emmanuel Bachy, Marc André, Nicolas Mounier, Christophe Fermé
Publikováno v:
Haematologica, Vol 100, Iss 12 (2015)
Nodular lymphocyte predominant Hodgkin lymphoma represents a distinct entity from classical Hodgkin lymphoma. We conducted a retrospective study to investigate the management of patients with nodular lymphocyte predominant Hodgkin lymphoma. Clinical
Externí odkaz:
https://doaj.org/article/4fc4dd1217f840bd9d0d282e1c069631
Autor:
Fabrice Jardin, Krimo Bouabdallah, Sandra Malak, Corinne Haioun, Alexandra-Cristina Paunescu, Vincent Ribrag, Gerhard Rumpold, Christiane Copie, Nicolas Mounier, David Sibon, Caroline Besson, Marie Preau, Steven Le Gouill
Publikováno v:
Annals of Hematology
Annals of Hematology, 2022, 101 (2), pp.317-332. ⟨10.1007/s00277-021-04689-4⟩
Annals of Hematology, 2022, 101 (2), pp.317-332. ⟨10.1007/s00277-021-04689-4⟩
Health-related quality of life (HRQoL) is a multidimensional concept including physical, emotional, social, and cognitive functions, disease symptoms, and side effects of treatment. Differences in HRQoL due to gender, existence of comorbidities, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137ca73de0d5d67d081ca162da1ea4da
https://pubmed.ncbi.nlm.nih.gov/34694443
https://pubmed.ncbi.nlm.nih.gov/34694443